Bittensor Revolutionizes Drug Discovery 65B Possibilities

Metanova Labs Innovates Drug Discovery with Decentralized AI

• Metanova Labs utilizes decentralized AI via the Bittensor network to efficiently screen billions of molecules, aiming to revolutionize drug discovery.
• Bittensor incentivizes contributions to AI models with crypto rewards, supporting applications like drug discovery and compute resource rental.
• The traditional drug discovery process is costly and lengthy, averaging $2.6 billion and ten years per drug.
• Metanova’s decentralized virtual screening proof of concept launched on March 1, expanding potential molecule datasets from one billion to approximately 65 billion through combinatorial reactions.
• The dual incentive mechanism allows miners to submit molecules or compete using chemical search algorithms, enhancing the virtual screening process.

Metanova Labs leverages a decentralized approach with Bittensor’s AI network to streamline drug discovery, significantly reducing costs and timelines by expanding molecular possibilities and incentivizing global creativity in the pharmaceutical industry.